3H-cholesterol bound to albumin ( DrugBank: Cholesterol )


2 diseases
IDDisease name (Link within this page)Number of trials
259Lecithin-cholesterol acyltransferase deficiency1
261Tangier disease1

259. Lecithin-cholesterol acyltransferase deficiency


Clinical trial : 1 Drugs : 2 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01782027
(ClinicalTrials.gov)
October 201230/1/2013Mendelian Reverse Cholesterol Transport StudyA Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL MetabolismCholesterol, HDL;Lipid Metabolism, Inborn Errors;Tangier Disease;LCAT Deficiency;Cholesteryl Ester Transfer Protein (CETP) DeficiencyDrug: 3H-cholesterol bound to albuminUniversity of PennsylvaniaNULLSuspended18 Years75 YearsAll30N/AUnited States

261. Tangier disease


Clinical trial : 1 Drugs : 2 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01782027
(ClinicalTrials.gov)
October 201230/1/2013Mendelian Reverse Cholesterol Transport StudyA Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL MetabolismCholesterol, HDL;Lipid Metabolism, Inborn Errors;Tangier Disease;LCAT Deficiency;Cholesteryl Ester Transfer Protein (CETP) DeficiencyDrug: 3H-cholesterol bound to albuminUniversity of PennsylvaniaNULLSuspended18 Years75 YearsAll30N/AUnited States